Results 321 to 330 of about 206,699 (375)

Use of Ultraviolet‐Induced Fluorescence Dermoscopy for the Diagnosis of Vitiligo‐Like Lesions in Patients Receiving Immune Checkpoint Inhibitors Therapy for Advanced Melanoma: Letter to the Editor

JEADV Clinical Practice, EarlyView.
Laura Rackauskaite, Diana C. O. Jimenez, Iris Zalaudek   +2 more
wiley   +1 more source

Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report.

World J Clin Cases
Jiang YJ, Wu L, Yang X, Pu Y, Ning BJ, Peng N, Zhu XJ.   +6 more
europepmc   +1 more source

Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib [PDF]

Clinical Lymphoma Myeloma and Leukemia, 2012
Introduction A 78-year-old man presented to our hospital with an indurated, painful lesion on the abdominal wall at the site of a recent subcutaneous (SC) bortezomib injection. The patient was diagnosed with multiple myeloma (MM) in 2007 after a bone marrow biopsy was done as part of anemia workup.
Richard Ferrara, Karam M. Obeid, Mamta Sharma   +2 more
openaire   +2 more sources

Central administration of perfluorooctanoic acid inhibits cutaneous inflammation [PDF]

Inflammation Research, 2005
To elucidate the site of action of perfluorooctanoic acid (PFOA) in the carrageenan model of peripheral inflammation.Male Sprague-Dawley rats.We first compared the anti-edema effects of systemic PFOA (50-150 mg/kg) with prototypical nonsteroidal (acetylsalicylic acid, ASA, 50-200 mg/kg) and steroidal (dexamethasone, 0.5-5.0 mg/kg) drugs after the ...
S. Nagalingam, N. Dadia, C. Kriedt, Bradley K. Taylor, Mostafa Z. Badr   +4 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cutaneous Administration of Nitroglycerin: A Review

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
Chronic administration of nitroglycerin may have important therapeutic effects in patients with angina, acute myocardial infarction, congestive heart failure and peripheral vascular disease. Because of unpredictable oral absorption and short duration of action, topical preparations provide an alternative mode of administration.
Jay N. Cohn, Maria-Teresa Olivari
openaire   +3 more sources

Cutaneous toxicity following the administration of dactinomycin

Medical and Pediatric Oncology, 1997
Dactinomycin (AMD) is an effective drug in the management of several malignant disorders and has been used for almost 40 years. Skin and subcutaneous toxicities following extravasation are well known and can be harmful. Similarly radiation-recall is a well established phenomenon following the administration of AMD.
John P. Arlette, Max J. Coppes, Keith Jorgenson   +2 more
openaire   +2 more sources

Cutaneous reaction associated with weekly docetaxel administration

Journal of Oncology Pharmacy Practice, 2008
Background. Docetaxel-based chemotherapy will remain clinically relevant and many of our patients will continue to receive the drug. In a recent phase 2 study of docetaxel 35 mg/m2 (weekly) in patients with metastatic breast cancer, the incidence of grade 3 cutaneous toxicity is 19%.
Chew, L., Chuen, V.S.L.
openaire   +3 more sources

Levodopa Administration and Multiple Primary Cutaneous Melanomas

Archives of Dermatology, 1980
Malignant melanoma derives from melanocytic cells that possess the special biochemical pathway for the conversion of levodopa to melanin. Levodopa is widely employed in the treatment of Parkinson's disease, and several patients receiving levodopa have been observed to have acquired melanomas, raising concern about a possible relationship between this ...
Allan L. Lorincz, Anne E. Solomon, Maria Medenica, Joel E. Bernstein, Keyoumars Soltani   +4 more
openaire   +3 more sources